DigitizingClinical Research
Medify is the integrated ePRO, eSource, and data collection platform purpose-built for clinical trials in Central and Eastern Europe. One system for patient data, investigator workflows, monitor oversight, and regulatory safety reporting.
The cost of inefficiency in clinical trials
Every handoff between disconnected systems costs time and money, and the trial absorbs both.
- $300B+
- Added medical costs
- Annual healthcare burden from medication non-adherence
- 50%
- Patient non-adherence
- Leading cause of preventable data loss
- 90%
- Drug candidates fail
- Each approved drug costs about $2.6B to develop
- $8M
- Lost per day
- Trial delays cost sponsors $600K–$8M per day
88% of dropouts are lost to follow-up, non-adherence or consent withdrawal.
27% of their time goes to documentation — as much as to direct patient care.
Traditional manual monitoring catches only 32% of data errors.
Three roles, three sets of gaps, one cause: the systems never meet. That is the gap Medify closes.
Connecting the missing links
One platform for patient data, investigator workflows and monitor oversight.
For Doctors
Instant, secure access to each patient's data through automated data flows and built-in integrations with trial-critical systems.
- Instantly enroll patients — one-time codes make onboarding fast and error-free
- Complete visibility over each patient, from health records to daily notebooks
- Automated alerts surface symptoms and missing data before the next visit
For Patients
Patients get into their trial with a one-time code, and everyday reporting stays fast and straightforward.
- Simple enrollment eliminates the paperwork between consent and first entry
- Daily check-ins take two minutes instead of twenty
- Report a health concern instantly — the doctor is notified immediately
For Monitors/CRAs
Monitoring moves from damage control to prevention. Instead of periodic site visits, monitors supervise continuously.
- A unified workspace showing every active study, its sites and enrolled patients
- Automated alerts for data gaps and late entries, so nothing is overlooked
- Pseudonymized records — diaries and visit history by study ID, never by name
Five modules on one data layer
Each module runs independently on a shared backend. Activate only what the protocol requires.
From first symptom to the regulator
Medify logs, timestamps, alerts and counts down. Every clinical classification is made and signed by the investigator.
Side effect
Patient-reported symptom, logged and timestamped. Not yet a clinical record.
Adverse event
Investigator assesses severity, causality and expectedness, then signs the record.
Serious adverse event
Any one of six ICH E2A criteria met. The regulatory clock starts on the checkbox.
SUSAR
Serious, unexpected and causally related. Expedited reporting to the authority.
Medify never classifies a safety event. Grading, causality and seriousness stay the investigator's medical judgment, entered and signed by them.
Server-side countdowns, visible to every role at once
- 24h
- Sponsor notification from investigator awareness
- 7 days
- Fatal or life-threatening SUSAR
- 15 days
- All other SUSARs, and follow-up reports
Built from 43 interviews with the people who run trials
27 clinical trial experts across 8 product iterations. What they told us is why Medify is one platform instead of five tools.
Founded
Started as a medication-adherence app for Bulgarian sites — one problem, one tool.
Scope widened
The interviews kept pointing past adherence. The expensive failures happened between systems, so we rebuilt as one platform.
In pilot
Late-stage MVP running at real clinical sites, offline-first and localized for CEE.
Pilot results, first month
- 92%
- of patients completed onboarding without site assistance
- 78%
- logged their data on any given day
- 90%
- of entries needed no query or correction
Latest insights
Field notes on ePRO, eSource and deployment in Central and Eastern Europe.
What Is ePRO and Why Clinical Trials in CEE Need It Now
Electronic Patient Reported Outcomes are reshaping how clinical trial data is captured at the source. For Central and Eastern Europe, the adoption gap is both a challenge and an opportunity.
Read articleGet in touch
Evaluating Medify for a study? Book a demo and we'll build it on your protocol. The form is for everything else.
Evaluating Medify for a study
A 30-minute walkthrough on your own protocol, and a reply within one business day.
Book a demo